XTX Topco Ltd Acquires Shares of 10,844 Phreesia, Inc. (NYSE:PHR)

XTX Topco Ltd bought a new position in shares of Phreesia, Inc. (NYSE:PHR) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,844 shares of the company’s stock, valued at approximately $247,000.

Other large investors have also recently made changes to their positions in the company. Deerfield Management Company L.P. Series C bought a new stake in Phreesia during the 2nd quarter valued at about $4,078,000. Champlain Investment Partners LLC increased its position in shares of Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares during the period. Sei Investments Co. raised its stake in shares of Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after acquiring an additional 95,058 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Phreesia by 56.3% in the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares during the period. Finally, State Street Corp grew its stake in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Michael Weintraub sold 20,565 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of $25.04, for a total value of $514,947.60. Following the completion of the transaction, the director now owns 242,827 shares in the company, valued at $6,080,388.08. This trade represents a 7.81 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Yvonne Hui sold 2,791 shares of the business’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total value of $58,387.72. Following the sale, the insider now owns 27,228 shares in the company, valued at approximately $569,609.76. The trade was a 9.30 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 86,823 shares of company stock valued at $1,953,660. Insiders own 5.80% of the company’s stock.

Phreesia Stock Down 3.4 %

Shares of PHR stock opened at $24.01 on Thursday. The stock’s fifty day moving average price is $20.66 and its 200 day moving average price is $21.90. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The company has a market cap of $1.40 billion, a price-to-earnings ratio of -16.33 and a beta of 0.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.58) earnings per share. On average, research analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research note on Friday, September 27th. JPMorgan Chase & Co. raised their target price on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday, September 9th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Finally, DA Davidson reissued a “buy” rating and set a $32.00 price objective on shares of Phreesia in a report on Thursday, September 5th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Phreesia has a consensus rating of “Moderate Buy” and an average price target of $29.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.